Related references
Note: Only part of the references are listed.Design, synthesis and biological evaluation of indanone-chalcone hybrids as potent and selective hCES2A inhibitors
Peng-Chao Huo et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)
Discovery and Characterization of the Biflavones From Ginkgo biloba as Highly Specific and Potent Inhibitors Against Human Carboxylesterase 2
Yun-Qing Song et al.
FRONTIERS IN PHARMACOLOGY (2021)
Detection techniques of carboxylesterase activity: An update review
Lulu Lan et al.
BIOORGANIC CHEMISTRY (2020)
Bioluminescent Sensor Reveals that Carboxylesterase 1A is a Novel Endoplasmic Reticulum -Derived Serologic Indicator for Hepatocyte Injury
Dan-Dan Wang et al.
ACS SENSORS (2020)
Bioactivity-Guided Discovery of Human Carboxylesterase Inhibitors from the Roots of Paeonia lactiflora
Jing-Fang Zhang et al.
JOURNAL OF NATURAL PRODUCTS (2020)
Characterization of Differential Tissue Abundance of Major Non-CYP Enzymes in Human
Abdul Basit et al.
MOLECULAR PHARMACEUTICS (2020)
Discovery of natural alkaloids as potent and selective inhibitors against human carboxylesterase 2
Yi-Shu Zhao et al.
BIOORGANIC CHEMISTRY (2020)
Discovery and characterization of pentacyclic triterpenoid acids in Styrax as potent and reversible pancreatic lipase inhibitors
Lu Wang et al.
JOURNAL OF FUNCTIONAL FOODS (2020)
The Impact of Carboxylesterases in Drug Metabolism and Pharmacokinetics
Li Di
CURRENT DRUG METABOLISM (2019)
Contribution of Human Liver and Intestinal Carboxylesterases to the Hydrolysis of Selexipag In Vitro
Shunji Imai et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2019)
In Vitro Inhibition of Carboxylesterase 1 by Major Cannabinoids and Selected Metabolites
Yuli Qian et al.
DRUG METABOLISM AND DISPOSITION (2019)
Rational Design of a Long-Wavelength Fluorescent Probe for Highly Selective Sensing of Carboxylesterase 1 in Living Systems
Zhenhao Tian et al.
ANALYTICAL CHEMISTRY (2019)
A natural inhibitor from Alisma orientale against human carboxylesterase 2: Kinetics, circular dichroism spectroscopic analysis, and docking simulation
Jing Yi et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2019)
Demethylbellidifolin isolated from Swertia bimaculate against human carboxylesterase 2: Kinetics and interaction mechanism merged with docking simulations
Tian-Tian Liu et al.
BIOORGANIC CHEMISTRY (2019)
Inhibition of human carboxylesterases by magnolol: Kinetic analyses and mechanism
Yun-Qing Song et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2019)
Discovery of a highly specific and efficacious inhibitor of human carboxylesterase 2 by large-scale screening
Yun-Qing Song et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2019)
Sensing carboxylesterase 1 in living systems by a practical and isoform-specific fluorescent probe
Lele Ding et al.
CHINESE CHEMICAL LETTERS (2019)
Evaluation of the inhibition of human carboxylesterases (CESs) by the active ingredients from Schisandra chinensis
Qiang Fu et al.
XENOBIOTICA (2019)
Inhibition of human carboxylesterases by ginsenosides: structure-activity relationships and inhibitory mechanism
Zhao-Hui Sun et al.
CHINESE MEDICINE (2019)
Discovery of dihydrooxazolo[2,3-a]isoquinoliniums as highly specific inhibitors of hCE2
Lixia Ding et al.
RSC ADVANCES (2019)
Predominant contributions of carboxylesterase 1 and 2 in hydrolysis of anordrin in humans
Jinfang Jiang et al.
XENOBIOTICA (2018)
Carboxylesterases in lipid metabolism: from mouse to human
Jihong Lian et al.
PROTEIN & CELL (2018)
Carboxylesterase-2-Selective Two-Photon Ratiometric Probe Reveals Decreased Carboxylesterase-2 Activity in Breast Cancer Cells
Sang Jun Park et al.
ANALYTICAL CHEMISTRY (2018)
Characterization and structure-activity relationship studies of flavonoids as inhibitors against human carboxylesterase 2
Zi-Miao Weng et al.
BIOORGANIC CHEMISTRY (2018)
Carboxylesterase Inhibitors: An Update
Li-Wei Zou et al.
CURRENT MEDICINAL CHEMISTRY (2018)
Evidence for Shikonin acting as an active inhibitor of human carboxylesterases 2: Implications for herb-drug combination
Jia-Nan Li et al.
PHYTOTHERAPY RESEARCH (2018)
Human carboxylesterases: a comprehensive review
Dandan Wang et al.
ACTA PHARMACEUTICA SINICA B (2018)
Nevadensin is a naturally occurring selective inhibitor of human carboxylesterase 1
Ya-Qiao Wang et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2018)
Potent, Irreversible Inhibition of Human Carboxylesterases by Tanshinone Anhydrides Isolated from Salvia miltiorrhiza (Danshen)
M. Jason Hatfield et al.
JOURNAL OF NATURAL PRODUCTS (2018)
Phytochemical constituents from Uncaria rhynchophylla in human carboxylesterase 2 inhibition: Kinetics and interaction mechanism merged with docking simulations
Ya-Li Wang et al.
PHYTOMEDICINE (2018)
Age-Dependent Absolute Abundance of Hepatic Carboxylesterases (CES1 and CES2) by LC-MS/MS Proteomics: Application to PBPK Modeling of Oseltamivir In Vivo Pharmacokinetics in Infants
Mikael Boberg et al.
DRUG METABOLISM AND DISPOSITION (2017)
Biopharmaceutical aspects and implications of excipient variability in drug product performance
P. Zarmpi et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2017)
Phenolic glycosides and monoterpenoids from the roots of Euphorbia ebracteolata and their bioactivities
An-Hua Wang et al.
FITOTERAPIA (2017)
Recent progress in the discovery of natural inhibitors against human carboxylesterases
Dan-Dan Wang et al.
FITOTERAPIA (2017)
Isoflavones and anti-inflammatory constituents from the fruits of Psoralea corylifolia
Chiang-Hsiang Chen et al.
PHYTOCHEMISTRY (2017)
Structure-Activity Relationships of Pentacyclic Triterpenoids as Potent and Selective Inhibitors against Human Carboxylesterase 1
Li-Wei Zou et al.
FRONTIERS IN PHARMACOLOGY (2017)
Ginseng in Dermatology: A Review
Sarvenaz Sabouri-Rad et al.
CURRENT PHARMACEUTICAL DESIGN (2017)
CES1 genetic variation affects the activation of angiotensin-converting enzyme inhibitors
X. Wang et al.
PHARMACOGENOMICS JOURNAL (2016)
Inhibition behavior of fructus psoraleae's ingredients towards human carboxylesterase 1 (hCES1)
Dong-Xue Sun et al.
XENOBIOTICA (2016)
A highly selective near-infrared fluorescent probe for carboxylesterase 2 and its bioimaging applications in living cells and animals
Qiang Jin et al.
BIOSENSORS & BIOELECTRONICS (2016)
A bioluminescent sensor for highly selective and sensitive detection of human carboxylesterase 1 in complex biological samples
Dan-Dan Wang et al.
CHEMICAL COMMUNICATIONS (2016)
Carboxylesterases: General detoxifying enzymes
M. Jason Hatfield et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2016)
Design, synthesis, and structure-activity relationship study of glycyrrhetinic acid derivatives as potent and selective inhibitors against human carboxylesterase 2
Li-Wei Zou et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2016)
Identification and characterization of naturally occurring inhibitors against human carboxylesterase 2 in White Mulberry Root-bark
Ya-Jing Liu et al.
FITOTERAPIA (2016)
Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys
Travis K. Warren et al.
NATURE (2016)
A highly selective marker reaction for measuring the activity of human carboxylesterase 1 in complex biological samples
Xia Lv et al.
RSC ADVANCES (2016)
Sacubitril Is Selectively Activated by Carboxylesterase 1 (CES1) in the Liver and the Activation Is Affected by CES1 Genetic Variation
Jian Shi et al.
DRUG METABOLISM AND DISPOSITION (2016)
The anti-hypertensive drug reserpine induces neuronal cell death through inhibition of autophagic flux
Kang Il Lee et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2015)
Carboxylesterase 1-Mediated Drug-Drug Interactions between Clopidogrel and Simvastatin
Xinwen Wang et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2015)
Effect of carboxylesterase 1 c.428G>A single nucleotide variation on the pharmacokinetics of quinapril and enalapril
E. Katriina Tarkiainen et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2015)
Comparison of substrate specificity among human arylacetamide deacetylase and carboxylesterases
Tatsuki Fukami et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2015)
Fructus Psoraleae contains natural compounds with potent inhibitory effects towards human carboxylesterase 2
Yao-Guang Li et al.
FITOTERAPIA (2015)
Protostane Triterpenoids from the Rhizome of Alisma orientale Exhibit Inhibitory Effects on Human Carboxylesterase 2
Zhen-Peng Mai et al.
JOURNAL OF NATURAL PRODUCTS (2015)
integrated phenotypic and activity-based profiling links Ces3 to obesity and diabetes
Eduardo Dominguez et al.
NATURE CHEMICAL BIOLOGY (2014)
The growing use of herbal medicines: issues relating to adverse reactions and challenges in monitoring safety
Martins Ekor
FRONTIERS IN PHARMACOLOGY (2014)
In Vitro Drug Metabolism by Human Carboxylesterase 1: Focus on Angiotensin-Converting Enzyme Inhibitors
Ragnar Thomsen et al.
DRUG METABOLISM AND DISPOSITION (2014)
Screening of Specific Inhibitors for Human Carboxylesterases or Arylacetamide Deacetylase
Mai Shimizu et al.
DRUG METABOLISM AND DISPOSITION (2014)
Identification of Carboxylesterase-Dependent Dabigatran Etexilate Hydrolysis
S. Casey Laizure et al.
DRUG METABOLISM AND DISPOSITION (2014)
Human Carboxylesterase-2 Hydrolyzes the Prodrug of Gemcitabine (LY2334737) and Confers Prodrug Sensitivity to Cancer Cells
Susan E. Pratt et al.
CLINICAL CANCER RESEARCH (2013)
Evaluation of the Inhibitory Effects of Antihypertensive Drugs on Human Carboxylesterase In Vitro
Xu Yanjiao et al.
DRUG METABOLISM AND PHARMACOKINETICS (2013)
Modulation of Esterified Drug Metabolism by Tanshinones from Salvia miltiorrhiza (Danshen)
M. Jason Hatfield et al.
JOURNAL OF NATURAL PRODUCTS (2013)
Effects of herbal supplements on the bioactivation of chemotherapeutic agents
Gregory S. Gorman et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2013)
The Role of Human Carboxylesterases in Drug Metabolism: Have We Overlooked Their Importance?
S. Casey Laizure et al.
PHARMACOTHERAPY (2013)
Carboxylesterase 1 as a Determinant of Clopidogrel Metabolism and Activation
Hao-Jie Zhu et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2013)
Species difference of esterase expression and hydrolase activity in plasma
Fatma Goksin Bahar et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2012)
Prediction and In Vitro Evaluation of Selected Protease Inhibitor Antiviral Drugs as Inhibitors of Carboxylesterase 1: A Potential Source of Drug-Drug Interactions
Jenna A. Rhoades et al.
PHARMACEUTICAL RESEARCH (2012)
Contributions of Arylacetamide Deacetylase and Carboxylesterase 2 to Flutamide Hydrolysis in Human Liver
Yuki Kobayashi et al.
DRUG METABOLISM AND DISPOSITION (2012)
Conclusive Identification of the Oxybutynin-Hydrolyzing Enzyme in Human Liver
Yuichiro Sato et al.
DRUG METABOLISM AND DISPOSITION (2012)
Carboxylesterases 1 and 2 Hydrolyze Phospho-Nonsteroidal Anti-Inflammatory Drugs: Relevance to Their Pharmacological Activity
Chi C. Wong et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2012)
Carboxylesterase 2 hydrolyzes a gemcitabine prodrug (LY2334737) and provides a patient tailoring biomarker
Susan E. Pratt et al.
CANCER RESEARCH (2011)
Antimicrobial effect of Magnolia officinalis extract against Staphylococcus aureus
Yongjin Hu et al.
JOURNAL OF THE SCIENCE OF FOOD AND AGRICULTURE (2011)
In silico prediction of human carboxylesterase-1 (hCES1) metabolism combining docking analyses and MD simulations
Giulio Vistoli et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2010)
The Role of Intestinal Carboxylesterase in the Oral Absorption of Prodrugs
Teruko Imai et al.
CURRENT DRUG METABOLISM (2010)
In Vitro Evaluation of Inhibitory Effects of Antidiabetic and Antihyperlipidemic Drugs on Human Carboxylesterase Activities
Tatsuki Fukami et al.
DRUG METABOLISM AND DISPOSITION (2010)
Involvement of Carboxylesterase 1 and 2 in the Hydrolysis of Mycophenolate Mofetil
Nobuhiro Fujiyama et al.
DRUG METABOLISM AND DISPOSITION (2010)
Metabolism and Disposition of the Thienopyridine Antiplatelet Drugs Ticlopidine, Clopidogrel, and Prasugrel in Humans
Nagy A. Farid et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2010)
Homology modeling and metabolism prediction of human carboxylesterase-2 using docking analyses by GriDock: a parallelized tool based on AutoDock 4.0
Giulio Vistoli et al.
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN (2010)
Carboxylesterases: dual roles in lipid and pesticide metabolism
Matthew K. Ross et al.
JOURNAL OF PESTICIDE SCIENCE (2010)
Recommended nomenclature for five mammalian carboxylesterase gene families: human, mouse, and rat genes and proteins
Roger S. Holmes et al.
MAMMALIAN GENOME (2010)
The Four-Herb Chinese Medicine PHY906 Reduces Chemotherapy-Induced Gastrointestinal Toxicity
Wing Lam et al.
SCIENCE TRANSLATIONAL MEDICINE (2010)
Identification of selected therapeutic agents as inhibitors of carboxylesterase 1: Potential sources of metabolic drug interactions
Hao-Jie Zhu et al.
TOXICOLOGY (2010)
Role of carboxylesterase 1 and impact of natural genetic variants on the hydrolysis of trandolapril
Hao-Jie Zhu et al.
BIOCHEMICAL PHARMACOLOGY (2009)
Human carboxylesterases HCE1 and HCE2: Ontogenic expression, inter-individual variability and differential hydrolysis of oseltamivir, aspirin, deltamethrin and permethrin
Dongfang Yang et al.
BIOCHEMICAL PHARMACOLOGY (2009)
Different Inhibitory Effects in Rat and Human Carboxylesterases
Shiori Takahashi et al.
DRUG METABOLISM AND DISPOSITION (2009)
In vitro stability and metabolism of salvinorin A in rat plasma
K. Tsujikawa et al.
XENOBIOTICA (2009)
Inhibition of carboxylesterase 1 is associated with cholesteryl ester retention in human THP-1 monocyte/macrophages
J. Allen Crow et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2008)
An improved human carboxylesterase for enzyme/prodrug therapy with CPT-11
M. Wierdl et al.
CANCER GENE THERAPY (2008)
Structure and catalytic properties of carboxylesterase isozymes involved in metabolic activation of prodrugs
Masakiyo Hosokawa
MOLECULES (2008)
Review of pharmacological effects of Glycyrrhiza sp and its bioactive compounds
Marjan Nassiri Asl et al.
PHYTOTHERAPY RESEARCH (2008)
Human Carboxylesterases and their role in xenobiotic and endobiotic metabolism
Matthew K. Ross et al.
JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY (2007)
Anti-influenza prodrug oseltamivir is activated by carboxylesterase human carboxylesterase 1, and the activation is inhibited by antiplatelet agent clopidogrel
Deshi Shi et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
Multisite promiscuity in the processing of endogenous substrates by human carboxylesterase 1
Sompop Bencharit et al.
JOURNAL OF MOLECULAR BIOLOGY (2006)
Substrate specificity of carboxylesterase isozymes and their contribution to hydrolase activity in human liver and small intestine
Teruko Imai et al.
DRUG METABOLISM AND DISPOSITION (2006)
Structure, function and regulation of carboxylesterases
Tetsuo Satoh et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2006)
Human carboxylesterase isozymes: Catalytic properties and rational drug design
Teruko Imai
DRUG METABOLISM AND PHARMACOKINETICS (2006)
Enzymes involved in the bioconversion of ester-based prodrugs
Bianca M. Liederer et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2006)
Danshen: An overview of its chemistry, pharmacology, pharmacokinetics, and clinical use
LM Zhou et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2005)
Butyrylcholinesterase, paraoxonase, and albumin esterase, but not carboxylesterase, are present in human plasma
B Li et al.
BIOCHEMICAL PHARMACOLOGY (2005)
Structural insights into drug processing by human carboxylesterase 1: Tamoxifen, mevastatin, and inhibition by benzil
CD Fleming et al.
JOURNAL OF MOLECULAR BIOLOGY (2005)
A single nucleotide polymorphism in the carboxylesterase gene is associated with the responsiveness to imidapril medication and the promoter activity
E Geshi et al.
HYPERTENSION RESEARCH (2005)
Hydrolysis of capecitabine to 5′-deoxy-5-fluorocytidine by human carboxylesterases and inhibition by loperamide
SK Quinney et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
Mammalian carboxylesterases: from drug targets to protein therapeutics
MR Redinbo et al.
DRUG DISCOVERY TODAY (2005)
Methylphenidate is stereoselectively hydrolyzed by human carboxylesterase CES1A1
ZJ Sun et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2004)
Human carboxylesterase 1: from drug metabolism to drug discovery
MR Redinbo et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2003)
Structural basis of heroin and cocaine metabolism by a promiscuous human drug-processing enzyme
S Bencharit et al.
NATURE STRUCTURAL BIOLOGY (2003)
Crystal structure of human carboxylesterase 1 complexed with the Alzheimer's drug tacrine: From binding promiscuity to selective inhibition
S Bencharit et al.
CHEMISTRY & BIOLOGY (2003)
Identification of two tamoxifen target proteins by photolabeling with 4-(2-morpholinoethoxy)benzophenone
F Mésange et al.
BIOCONJUGATE CHEMISTRY (2002)
Involvement of liver carboxylesterases in the in vitro metabolism of lidocaine
SEH Alexson et al.
DRUG METABOLISM AND DISPOSITION (2002)
Structural insights into CPT-11 activation by mammalian carboxylesterases
S Bencharit et al.
NATURE STRUCTURAL BIOLOGY (2002)
Proteome analysis of hepatocellular carcinoma
SO Lim et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2002)
Kinetics of the acidic and enzymatic hydrolysis of benazepril HCl studied by LC
M Gana et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2002)
Share Paper
